Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Prepaid Assets (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Prepaid Assets for 4 consecutive years, with $3.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets changed N/A to $3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.5 million, a N/A change, with the full-year FY2024 number at $13.4 million, up 50.25% from a year prior.
  • Prepaid Assets was $3.5 million for Q3 2025 at Day One Biopharmaceuticals, up from $1.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $402.5 million in Q2 2022 to a low of $782000.0 in Q1 2023.
  • A 4-year average of $49.8 million and a median of $4.0 million in 2025 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 787.38% in 2023, then crashed 85.11% in 2025.
  • Day One Biopharmaceuticals' Prepaid Assets stood at $1.0 million in 2022, then surged by 787.38% to $8.9 million in 2023, then skyrocketed by 50.25% to $13.4 million in 2024, then plummeted by 73.67% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Prepaid Assets are $3.5 million (Q3 2025), $1.8 million (Q2 2025), and $4.0 million (Q1 2025).